Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Crescentic glomerulonephritis].

Vincent Louis-Marie Esnault1, Anne Moreau, Angelo Testa

  • 1Service de Néphrologie-Immunologie Clinique, Hotel-Dieu, 1, place Alexis-Ricordeau, 44093 Nantes cedex 01, France. vincent.esnault@chu-nantes.fr

Nephrologie & Therapeutique
|December 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repeat kidney biopsy in patients with ANCA-associated vasculitis and suspected kidney relapse.

Clinical kidney journal·2026
Same author

Myeloperoxidase anti-neutrophil cytoplasmic antibody vasculitis mimicking renal polyarteritis nodosa.

Journal of nephrology·2026
Same author

Response to Rituximab as a Maintenance Therapy in Adult Idiopathic Nephrotic Syndrome: A French Multicenter Cohort Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2025
Same author

Distribution reappraisal of peripheral T- and NK-cell lymphoma entities through the French Lymphopath network database.

HemaSphere·2025
Same author

Recurrence of CKD-associated pruritus after discontinuation of difelikefalin.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2025
Same author

CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma.

The New England journal of medicine·2025

Crescentic glomerulonephritis involves kidney damage and rapid kidney failure. Early diagnosis and treatment with immunosuppressants are crucial for managing this condition and preventing further complications.

Area of Science:

  • Nephrology
  • Immunopathology

Context:

  • Crescentic glomerulonephritis is a severe kidney disease characterized by rapid glomerular destruction.
  • Diagnosis relies on kidney biopsy and immunofluorescence to identify immune deposits.

Purpose:

  • To outline the classification, diagnosis, and treatment of crescentic glomerulonephritis.
  • To highlight the role of immunofluorescence and ANCA testing in disease categorization.

Summary:

  • Patients present with rapidly progressive glomerulonephritis (RPGN), including renal failure, proteinuria, and hematuria.
  • Classification into three groups based on immunofluorescence (linear deposits, immune complex deposits, or pauci-immune) guides treatment.
  • Treatment involves immunosuppressants like steroids and cyclophosphamide, with plasma exchange for Goodpasture's disease.

Related Experiment Videos

Impact:

  • Urgent treatment is required to prevent irreversible kidney damage.
  • Understanding disease classification aids in targeted therapy and prognosis.
  • Research into less aggressive treatments is needed due to high rates of infection and cancer with current therapies.